The trusted source for
healthcare information and
Baxter and FDA warned of heparin risk in 2007
This is an excerpt from the "Important Medi-cation Safety Alert" that was issued on Feb. 6, 2007, by Baxter Healthcare Corp. and the Food and Drug Administration involving Heparin Sodium Injection 10,000 units/mL and HEP-LOCK U/P 10 units/mL:
The currently marketed 1 mL vials of Heparin Sodium Injection 10,000 units/mL and the HEP-LOCK U/P 10 units/mL use shades of blue as the prominent background color on their labels. Healthcare professionals should be reminded to:
The alert goes on to say that providers should "ensure that all staff responsible for the dispensing and administration of Heparin Sodium Injection and HEP-LOCK U/P products are aware of these medication errors and that the staff are familiar with your policies and procedures."
Baxter says risk managers with further questions can contact the company at (800) 262-3784. The full text of the alert, including photographs of the products, is available at the FDA web site at www.fda.gov. Enter "heparin medication safety alert" in the search box at the upper left of the home page, and then click on "IMPORTANT MEDICATION SAFETY ALERT."